NSTM (NovelStem International) 12-1 Month Momentum %: -41.05% (As of Sep. 20, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is NovelStem International 12-1 Month Momentum %?

NovelStem International NSTM 12-1 Month Momentum % is -41.05% as of Sep. 20, 2026. The stock has 3 warning signs investors should review. Among 210 Medical Diagnostics & Research companies, NovelStem International ranks worse than 80.95% on this metric.

12-1 Month Momentum % is the total return of the stock from 12-month ago to 1-month ago. As of today (2026-09-20), NovelStem International's 12-1 Month Momentum % is -41.05%.

The industry rank for NovelStem International's 12-1 Month Momentum % or its related term are showing as below:

NSTM's 12-1 Month Momentum % is ranked worse than
80.95% of 210 companies
in the Medical Diagnostics & Research industry
Industry Median: -10.3 vs NSTM: -41.05

NovelStem International  (OTCPK:NSTM) 12-1 Month Momentum % Explanation

Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 12-1 Month Momentum % measures the total return to a stock over the past twelve months, but ignores the previous month.

The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.

NovelStem International 12-1 Month Momentum % Related Terms

NSTM vs NOTVQ, PRPH, FUNI: 12-1 Month Momentum % Comparison

For the Diagnostics & Research subindustry, NovelStem International's 12-1 Month Momentum %, along with its competitors' market caps and 12-1 Month Momentum % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

NovelStem International 12-1 Month Momentum % vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, NovelStem International's 12-1 Month Momentum % distribution charts can be found below:

* The bar in red indicates where NovelStem International's 12-1 Month Momentum % falls into.


NovelStem International  (OTCPK:NSTM) 12-1 Month Momentum % Calculation

12-1 Month Momentum % is calculated as following:

12-1 Month Momentum %=( Price 1-month ago / Price 12-month ago - 1 ) * 100 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about 12-1 Month Momentum % →
What does a 12-1 Month Momentum % of -41.05% mean?
NovelStem International (NSTM) has a 12-1 Month Momentum % of -41.05% as of Sep. 20, 2026. 12-1 Month Momentum measures the total return of the stock from 12-month ago to 1-month ago. View historical data on NovelStem International and its competitors. According to the industry distribution chart, NovelStem International ranks #170 out of 210 companies in the Medical Diagnostics & Research industry, placing it in the top 81%.
Is NovelStem International's 12-1 Month Momentum % too high?
NovelStem International's current 12-1 Month Momentum % is -41.05%. Based on the distribution chart, NovelStem International ranks #170 out of 210 companies in the Medical Diagnostics & Research industry, which is in the bottom quartile relative to peers.
How does NovelStem International's 12-1 Month Momentum % compare to NOTVQ and PRPH?
According to the Medical Diagnostics & Research industry distribution chart, NovelStem International ranks #170 out of 210 companies for 12-1 Month Momentum %. This places NovelStem International in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 12-1 Month Momentum % for a Medical Diagnostics & Research company?
A good 12-1 Month Momentum % depends on the Medical Diagnostics & Research industry context. However, 12-1 Month Momentum % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 12-1 Month Momentum % mean?
A high 12-1 Month Momentum % can signal that a stock is expensive relative to its fundamentals. 12-1 Month Momentum measures the total return of the stock from 12-month ago to 1-month ago. View historical data on NovelStem International and its competitors. NovelStem International's current 12-1 Month Momentum % is -41.05%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is NovelStem International stock overvalued right now?
NovelStem International (NSTM) has a current 12-1 Month Momentum % of -41.05%. The current 12-1 Month Momentum % is -41.05%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 12-1 Month Momentum % calculated?
12-1 Month Momentum % is calculated from a company's financial statements. For NovelStem International (NSTM), the current 12-1 Month Momentum % is -41.05% as of Sep. 20, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

NovelStem International Business Description

Address 7740 Cavern Lane, Suite 100, Parkland, FL, USA, 33067
NovelStem International Corp is a holding company. Through its subsidiaries, the company is engaged in the development and commercialization of diagnostic technology that can predict patients' anti-cancer drug resistance, allowing for targeted cancer treatments and the potential to reduce resistance to chemotherapy. The company also has an interest in a book publishing franchise.